DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio
n

Friday 13 February 2015

Dr. Vasanth K Nalam



Dr. Vasanth K Nalam

DGM-R&D at Suven Life Sciences Ltd.
Previous
  1. Glenmark Research Centre
  2. Lupin Limited. (Research Park),
  3. Unichem Laboratories Ltd
Education
  1. University of Mumbai



Email
vknalam@suven.com












Nalam Vasanth Kumar



Summary

More than 20 years of rich experience in process research for API’s, new chemical entities (NCE’s), custom chemical synthesis (CCS) and contract research & manufacturing services (CRAMS) with reputed pharmaceutical organizations. Good understanding and analytical capabilities over various research areas (Medicinal chemistry & process research) and different business segments like APIs, CCS business.

Role and Responsibilities:

-New synthetic route identification.
-Development of non-infringing synthetic routes for Generic API’s and new chemical entities (NCE) with multiple-step chemistry and Scale-up varies therapeutic areas in a cost effective and environment friendly manner.
-Selection of cost effective suitable synthetic route for commercialization (Process research).
-Process optimization and process robustness demonstration from lab scale to commercial supplies (process development)
-Project leadership roles.
-Managing large team, team building, motivation and drive the team to achieve target.

Professional Experience:

-Complete project management includes heading a group of scientists working in various kind of projects (API, CCS)
-Providing sound technical proposals (chemistry selection, estimation of cost and timelines) & project plans for the custom synthesis and contract research for various clients.
-Responsible to meet the timeline for DMF filings as per business plan.
-Responsible for addressing the regulatory and business queries.
-Responsible for successful scale-up of technology at plant.
-Trouble shooting in Kilo lab/PP/Plant
-Identification of cost contributors and reduction of cost for better project margins and competitive advantage during the execution of projects.

Experience






DGM-R&D

Suven Life Sciences Ltd.
 – Present (6 years plus







Principal Scientist

Glenmark Research Centre
 –  (2 years)Mumbai






Research Scientist

Lupin Limited. (Research Park)
 –  (2 years 11 months)Pune






Group Leader

Unichem Laboratories Ltd
 –  (2 years 3 months)Pharmaceutical Company India - Unichem Laboratories Ltd.







Research Associate

Dr Reddys Labs
 –  (9 years 4 months)


Education





University of Mumbai

Ph.D




Kakatiya University

M.Sc, Chemistry

Kakatiya University

Warangal Area, India


Kakatiya University






Research Publications
Ü Process Research and Development of Melatonin
    C. Prabhakar, N.Vasanth Kumar, M. Ravikanth Reddy, M.R. Sarma and G. Om Reddy.
    Organic Process Research & Development 1999, 3, 155-160
Ü Synthesis and Biological activity of novel Anti-bacterial Quinolones
M R Sarma, N Vasanth Kumar, A S R Prasad, S Eswaraiah, C Prabhakar, G Om Reddy, M Sitaram Kumar, A K Sadhukhan, A Venkateswarlu & K Anji Reddy. Indian Journal of Chemistry. Vol. 40B, 2001, 331-335
Ãœ Synthesis of some novel   ethyl 6-cyano-7-substituted-5-methyl-2-oxo-2H-pyrano [2, 3-b] pyridine-3-carboxylate derivatives. N Vasanth Kumar & Uday C Mashelker.  Indian J Chem. 45B, 2006, 1770.
Ü Diasteroselective synthesis of some novel Benzopyranopyridine derivatives.
Pradeep K Mohakhud, Sujeet Kumar, N Vasanth Kumar, V. Ravi Kumar, J. Moses Babu, K. Vyas and G Om Reddy, Beilstein Journal of Organic Chemistry 2006, 2:25  
Ãœ Synthesis of novel 1,2,4-oxadiazole heterocyclic compounds contain 2-H-pyranopyridine-2-one moiety and related compounds. N Vasanth Kumar & Uday C Mashelker.  Indian Journal of Chemistry, 46B, 2007, 216.
Ãœ Synthesis of novel 3-substituted derivatives of 2H-pyrano[2,3-b]pyridine-2-one moiety 
N Vasanth Kumar & Uday C Mashelkar. Journal of Indian Chemical Society, Vol. 84,October 2007, 1048-1051.
Ü Synthesis of new heterocyclic compounds containing 2H-pyrano-[2,3-b]pyridine-2-one moiety
N Vasanth Kumar & Uday C Mashelkar, Indian Journal of Heterocyclic Chemistry, Vol. 17, July-Sept., 2007, 99-100
Ü Synthesis of some novel 1,2,4-triazolo[4,3-a]-2H-pyrano[3,2-e] pyridine derivatives.
N Vasanth Kumar & Uday C Mashelkar,  Heterocyclic Communications, Vol. 13, No. 4, 2007, 211-214.





Patents & Patent Applications
Ü A novel method for the preparation of aryl piperazinyl heterocyclic compounds.
   Tyagi Om dutt; Srivastava Tushar kumar; Chauhan Yogendra Kumar; Nalam Vasanth Kumar WO
   2006/011157 A2.
Ü Preparation of [2-Methyl-5Phenyl-3-(Piperazin-1-yl Methyl)] Pyrrole Derivatives
     Arora Sudershan Kumar; Sinha Neelima; Jain Sanjay; Upadhayaya Ram Shankar; Tyagi Om Dutt; Nalam
    Vasanth; Chauhan Yogendra Kumar WO 2006/ 109323 A1.
Ü Preparation of (2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)) pyrrole derivatives
    Nalam Vasanth; Chauhan yogendra Kumar; Upadhayaya Ram Shankar; Sinha Neelima; Jain Sanjay;
    Tyagi Om Dutt; Arora Sudershan Kumar AU2006233943

Ü Novel Method for the Preparation of Aryl Piperazinyl-Heterocyclic Compounds

    Tyagi Om D; Srivastava Tushar k ; Chauhan Yogendra K ; Nalam Vasanth K US2007238877
Ãœ Improved Process for the preparation of 7-amino-3-alkyl-3-cephem-4-carboxylic acid   compounds. Application 961/MUM/2004 published 2007-04-27, filed 2004-09-08
Ü A process for the preparation of novel crystalline form of Ziprasidone base.
    Application 1118/MUM/2004 published 2007-06-08, filed 2004-10-19
Ü A process for the preparation of novel crystalline form of Ziprasidone Hydrochloride Monohydrate Salt.
Application 1119/MUM/2004 published 2007-06-08, filed 2004-10-19.
Ü Improved Process for the manufacture of Ziprasidone.
     Tyagi Om D; Srivastava Tushar k ; Chauhan Yogendra K ; Nalam Vasanth K, Patil Sadanand Nilkanth.
WO2010010566A1.














HIS FAMILY



VASANTH KUMAR


 


 
 




HYDERABAD










No comments:

Post a Comment